Arkolith/Insider Trading/MLTX/Form 4

Santos da Silva Jorge

Chief Executive Officer, DirectorMoonLake Immunotherapeutics (MLTX) · full profile →Form 4 · filed Feb 29, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.8M
Net Open-Market Flow
-$6.8M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 29, 2024Sell(S)5K$55.89$265K3.0M
Feb 28, 2024Sell(S)56K$55.00$3.1M3.0M
Feb 27, 2024Sell(S)63K$55.00$3.5M3.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-018675) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML